FdaApplication

ANDA 210609

Back to search

Identifiers

Properties

PropertyValue
applicant_namePRINSTON PHARMACEUTICAL INC
application_typeANDA
approval_date2022-08-11

Products (4)

ProductActive ingredientStrengthDosage form
TADALAFILTADALAFIL10MGTABLET;ORAL
TADALAFILTADALAFIL5MGTABLET;ORAL
TADALAFILTADALAFIL2.5MGTABLET;ORAL
TADALAFILTADALAFIL20MGTABLET;ORAL

4 products